iohexol has been researched along with Carcinoma, Renal Cell in 48 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
Excerpt | Relevance | Reference |
---|---|---|
"Fifty-six cases of renal carcinoma confirmed by histopathology underwent conventional plain CT and contrast-enhanced spectral CT at arterial phase (AP) and venous phase (VP)." | 1.62 | Replacing true unenhanced imaging in renal carcinoma with virtual unenhanced images in dual-energy spectral CT: a feasibility study. ( Dang, S; Dou, Y; Han, D; Jin, C; Ma, G; Yang, C; Yang, Q; Yu, N, 2021) |
"Eighty-five tumors were renal cell carcinoma (RCC) (56 clear cell, 20 papillary, 9 chromophobe) and 10 were benign (6 angiomyolipoma,4 oncocytoma)." | 1.51 | Usefulness of rapid kV-switching dual energy CT in renal tumor characterization. ( Çamlıdağ, İ; Danacı, M; Nural, MS; Özden, E, 2019) |
"69 patients with metastatic renal cell carcinoma had dynamic contrast-enhanced CT scans at baseline and after 5 and 10 weeks of treatment." | 1.48 | Use of patient outcome endpoints to identify the best functional CT imaging parameters in metastatic renal cell carcinoma patients. ( Donskov, F; Madsen, HHT; Mains, JR; Pedersen, EM; Rasmussen, F; Thorup, K; Thygesen, J, 2018) |
"Papillary renal cell carcinoma (pRCC) and clear cell renal cell carcinoma (ccRCC) have different biological behaviours and imaging features." | 1.42 | Papillary renal cell carcinoma and clear cell renal cell carcinoma: Differentiation of distinct histological types with contrast - enhanced ultrasonography. ( Huang, BJ; Li, CX; Li, Z; Lu, Q; Wang, WP; Wen, JX; Xue, LY, 2015) |
"CTTA software was used to analyze 20 clear cell renal cell carcinomas (RCCs), 20 papillary RCCs, 20 oncocytomas, and 20 renal cysts." | 1.40 | CT texture analysis of renal masses: pilot study using random forest classification for prediction of pathology. ( Chen, Y; Fishman, EK; Huang, P; Raman, SP; Schroeder, JL, 2014) |
"To compare the rate of detection of renal cell carcinoma metastases to the pancreas between arterial and portal venous phase MDCT." | 1.39 | Renal cell carcinoma metastases to the pancreas: value of arterial phase imaging at MDCT. ( Corwin, MT; Lamba, R; McGahan, JP; Wilson, M, 2013) |
"Subtype differentiation of small renal cell carcinomas (RCCs) can provide more information to surgeons and patients and get more useful information about imaging features of small renal tumors." | 1.38 | Subtype differentiation of small renal cell carcinomas on three-phase MDCT: usefulness of the measurement of degree and heterogeneity of enhancement. ( Cho, JY; Jung, SC; Kim, SH, 2012) |
"During the excretory phase, ccRCCs with trisomy 5 enhanced more than those without this anomaly (115." | 1.37 | Clear cell renal cell carcinoma: multiphasic multidetector CT imaging features help predict genetic karyotypes. ( Belldegrun, AS; Hsu, MS; Lu, DS; Margolis, DJ; Pantuck, AJ; Raman, SS; Rao, NP; Sauk, SC, 2011) |
"In 28 patients with primary renal cell carcinoma a multislice CT scan of the thorax, abdomen, and pelvis, and a whole-body MRI were carried out as part of the postoperative follow-up." | 1.36 | Whole-body MRI in follow-up of patients with renal cell carcinoma. ( Deppe, PE; Grimm, MO; Laniado, M; Platzek, I; Stroszczynski, C; Wirth, M; Zastrow, S, 2010) |
"Two renal cell carcinomas were overlooked by the interpreters of the helical scans in group 1." | 1.30 | Dual-phase helical CT of the kidney: value of the corticomedullary and nephrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma. ( Fischer, U; Grabbe, E; Kopka, L; Ringert, RH; Schmidt, C; Zoeller, G, 1997) |
"In early stage renal carcinoma CT and MR imaging yielded similar staging accuracies." | 1.30 | [The staging of renal-cell carcinomas in MRT and CT--a prospective histologically controlled study]. ( Drehmer, I; Hallscheidt, P; Kauffmann, GW; Pomer, S; Roeren, T; Stolte, E, 1998) |
"Eighteen renal cell carcinomas and 8 other tumours were found; 78 kidneys had cysts, 12 polycystic kidneys and 10 fibrotic kidneys were detected, 20 kidneys showed other findings." | 1.30 | Renal masses--evaluation by amplitude coded colour Doppler sonography and multiphasic contrast-enhanced CT. ( Dörfler, O; Kugler, C; Preidler, K; Riccabona, M; Schreyer, HH; Szolar, D; Uggowitzer, M, 1999) |
"The masses included 27 renal cell carcinomas, two transitional cell carcinomas, one leiomyoma, one angiomyolipoma, and four benign cysts." | 1.29 | Small (< or = 3 cm) renal masses: correlation of spiral CT features and pathologic findings. ( Adams, DF; Bloom, DA; Corless, CL; Lee, BY; Seltzer, SE; Silverman, SG, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (10.42) | 18.2507 |
2000's | 4 (8.33) | 29.6817 |
2010's | 36 (75.00) | 24.3611 |
2020's | 3 (6.25) | 2.80 |
Authors | Studies |
---|---|
Tang, Z | 1 |
Yu, D | 1 |
Ni, T | 1 |
Zhao, T | 1 |
Jin, Y | 1 |
Dong, E | 1 |
Manoharan, D | 1 |
Netaji, A | 1 |
Das, CJ | 1 |
Sharma, S | 1 |
Ma, G | 1 |
Han, D | 1 |
Dang, S | 1 |
Yu, N | 1 |
Yang, Q | 1 |
Yang, C | 1 |
Jin, C | 1 |
Dou, Y | 1 |
Kim, YH | 1 |
Han, K | 1 |
Oh, YT | 1 |
Jung, DC | 1 |
Cho, NH | 1 |
Park, SY | 2 |
Dai, C | 1 |
Cao, Y | 1 |
Jia, Y | 1 |
Ding, Y | 1 |
Sheng, R | 1 |
Zeng, M | 1 |
Zhou, J | 1 |
Mains, JR | 1 |
Donskov, F | 1 |
Pedersen, EM | 1 |
Madsen, HHT | 1 |
Thygesen, J | 1 |
Thorup, K | 1 |
Rasmussen, F | 1 |
Çamlıdağ, İ | 1 |
Nural, MS | 1 |
Danacı, M | 1 |
Özden, E | 1 |
Coy, H | 2 |
Hsieh, K | 1 |
Wu, W | 1 |
Nagarajan, MB | 1 |
Young, JR | 4 |
Douek, ML | 2 |
Brown, MS | 2 |
Scalzo, F | 1 |
Raman, SS | 5 |
Sun, J | 1 |
Zhang, XY | 1 |
Li, XT | 1 |
Li, YL | 1 |
Wang, ZL | 1 |
Egbert, ND | 1 |
Caoili, EM | 1 |
Cohan, RH | 1 |
Davenport, MS | 1 |
Francis, IR | 1 |
Kunju, LP | 1 |
Ellis, JH | 1 |
Woo, S | 2 |
Cho, JY | 3 |
Kim, SH | 4 |
Kim, SY | 2 |
He, J | 2 |
Huan, Y | 1 |
Qiao, Q | 1 |
Zhang, J | 1 |
Zhang, JS | 1 |
Bata, P | 1 |
Tarnoki, DL | 1 |
Tarnoki, AD | 1 |
Novak, PK | 1 |
Gyebnar, J | 1 |
Kekesi, D | 1 |
Szendroi, A | 1 |
Fejer, B | 1 |
Szasz, AM | 1 |
Nyirady, P | 1 |
Karlinger, K | 1 |
Berczi, V | 1 |
Durack, JC | 1 |
Richioud, B | 1 |
Lyon, J | 1 |
Solomon, SB | 1 |
Margolis, D | 2 |
Sauk, S | 2 |
Pantuck, AJ | 3 |
Sayre, J | 3 |
Young, JA | 1 |
Hsu, M | 1 |
Thian, Y | 1 |
Gutzeit, A | 1 |
Koh, DM | 1 |
Fisher, R | 1 |
Lote, H | 1 |
Larkin, J | 1 |
Sohaib, A | 1 |
Raman, SP | 1 |
Chen, Y | 1 |
Schroeder, JL | 1 |
Huang, P | 1 |
Fishman, EK | 1 |
Xue, LY | 1 |
Lu, Q | 1 |
Huang, BJ | 1 |
Li, Z | 1 |
Li, CX | 1 |
Wen, JX | 1 |
Wang, WP | 1 |
Kang, TW | 1 |
Lee, J | 1 |
Kim, AY | 1 |
Jang, KM | 1 |
Choi, D | 1 |
Kim, MJ | 2 |
Zhou, K | 1 |
Zhu, B | 1 |
Zhang, G | 1 |
Li, X | 1 |
Guo, H | 1 |
Gan, W | 1 |
Zhou, Z | 1 |
Liu, T | 1 |
Paño, B | 1 |
Macías, N | 1 |
Salvador, R | 1 |
Torres, F | 1 |
Buñesch, L | 1 |
Sebastià, C | 1 |
Nicolau, C | 1 |
Choi, SY | 1 |
Sung, DJ | 1 |
Yang, KS | 1 |
Kim, KA | 1 |
Yeom, SK | 1 |
Sim, KC | 1 |
Han, NY | 1 |
Park, BJ | 1 |
Cho, SB | 1 |
Lee, JH | 1 |
Cupido, BD | 1 |
Sam, M | 1 |
Winters, SD | 1 |
Ahmed, B | 1 |
Seidler, M | 1 |
Huang, G | 1 |
Low, G | 1 |
Zarzour, JG | 1 |
Milner, D | 1 |
Valentin, R | 1 |
Jackson, BE | 1 |
Gordetsky, J | 1 |
West, J | 1 |
Rais-Bahrami, S | 1 |
Morgan, DE | 1 |
Kaneoya, K | 1 |
Ueda, T | 1 |
Suito, H | 1 |
Nanazawa, Y | 1 |
Tamaru, J | 1 |
Isobe, K | 1 |
Naya, Y | 1 |
Tobe, T | 1 |
Motoori, K | 1 |
Yamamoto, S | 1 |
Rubin, GD | 1 |
Minami, M | 1 |
Ito, H | 1 |
Platzek, I | 1 |
Zastrow, S | 1 |
Deppe, PE | 1 |
Grimm, MO | 1 |
Wirth, M | 1 |
Laniado, M | 1 |
Stroszczynski, C | 1 |
Smith, AD | 1 |
Shah, SN | 1 |
Rini, BI | 1 |
Lieber, ML | 1 |
Remer, EM | 1 |
Gakis, G | 1 |
Kramer, U | 1 |
Schilling, D | 1 |
Kruck, S | 1 |
Stenzl, A | 1 |
Schlemmer, HP | 1 |
Sauk, SC | 1 |
Hsu, MS | 1 |
Margolis, DJ | 1 |
Lu, DS | 1 |
Rao, NP | 1 |
Belldegrun, AS | 1 |
Jung, SC | 1 |
Hindman, NM | 1 |
Bosniak, MA | 1 |
Rosenkrantz, AB | 1 |
Lee-Felker, S | 1 |
Melamed, J | 1 |
Zamboni, GA | 1 |
Bernardin, L | 1 |
Pozzi Mucelli, R | 1 |
Rossi, G | 1 |
Mavrogenis, AF | 1 |
Casadei, R | 1 |
Bianchi, G | 1 |
Romagnoli, C | 1 |
Rimondi, E | 1 |
Ruggieri, P | 1 |
Tsili, AC | 1 |
Argyropoulou, MI | 1 |
Gousia, A | 1 |
Kalef-Ezra, J | 1 |
Sofikitis, N | 1 |
Malamou-Mitsi, V | 1 |
Tsampoulas, K | 1 |
Choi, YA | 1 |
Kim, CK | 1 |
Park, BK | 1 |
Kim, B | 1 |
Corwin, MT | 1 |
Lamba, R | 1 |
Wilson, M | 1 |
McGahan, JP | 1 |
Reiner, CS | 1 |
Roessle, M | 1 |
Thiesler, T | 1 |
Eberli, D | 1 |
Klotz, E | 1 |
Frauenfelder, T | 1 |
Sulser, T | 1 |
Moch, H | 1 |
Alkadhi, H | 1 |
Kim, JK | 1 |
Shon, JH | 1 |
Cho, KS | 1 |
Ruppert-Kohlmayr, AJ | 1 |
Uggowitzer, M | 2 |
Meissnitzer, T | 1 |
Ruppert, G | 1 |
Jinzaki, M | 1 |
Silverman, SG | 2 |
Tanimoto, A | 1 |
Shinmoto, H | 1 |
Kuribayashi, S | 1 |
Lee, BY | 1 |
Seltzer, SE | 1 |
Bloom, DA | 1 |
Corless, CL | 1 |
Adams, DF | 1 |
Kopka, L | 1 |
Fischer, U | 1 |
Zoeller, G | 1 |
Schmidt, C | 1 |
Ringert, RH | 1 |
Grabbe, E | 1 |
Hallscheidt, P | 1 |
Stolte, E | 1 |
Roeren, T | 1 |
Pomer, S | 1 |
Drehmer, I | 1 |
Kauffmann, GW | 1 |
Riccabona, M | 1 |
Szolar, D | 1 |
Preidler, K | 1 |
Kugler, C | 1 |
Dörfler, O | 1 |
Schreyer, HH | 1 |
Fishman, JE | 1 |
Aberle, DR | 1 |
Moldawer, NP | 1 |
Belldegrun, A | 1 |
Figlin, RA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Clinical Evaluation of Neoadjuvant Chemotherapy for Primary Malignant Sarcomas That Originate in Bone: a Multi-center Retrospective Study for Standardization and Modification of Response Evaluation Criteria[NCT03742063] | 190 participants (Actual) | Observational | 2017-06-01 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for iohexol and Carcinoma, Renal Cell
Article | Year |
---|---|
Quantitative Analysis of Multiphase Contrast-Enhanced CT Images: A Pilot Study of Preoperative Prediction of Fat-Poor Angiomyolipoma and Renal Cell Carcinoma.
Topics: Adult; Aged; Angiomyolipoma; Carcinoma, Renal Cell; Contrast Media; Female; Humans; Iohexol; Kidney | 2020 |
47 other studies available for iohexol and Carcinoma, Renal Cell
Article | Year |
---|---|
Iodine Parameters in Triple-Bolus Dual-Energy CT Correlate With Perfusion CT Biomarkers of Angiogenesis in Renal Cell Carcinoma.
Topics: Adult; Aged; Carcinoma, Renal Cell; Contrast Media; Female; Humans; Iohexol; Kidney Neoplasms; Male; | 2020 |
Replacing true unenhanced imaging in renal carcinoma with virtual unenhanced images in dual-energy spectral CT: a feasibility study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Contrast Media; Feasibility Studies; Female; | 2021 |
Morphologic analysis with computed tomography may help differentiate fat-poor angiomyolipoma from renal cell carcinoma: a retrospective study with 602 patients.
Topics: Angiomyolipoma; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Female; Humans; Iohe | 2018 |
Differentiation of renal cell carcinoma subtypes with different iodine quantification methods using single-phase contrast-enhanced dual-energy CT: areal vs. volumetric analyses.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Fema | 2018 |
Use of patient outcome endpoints to identify the best functional CT imaging parameters in metastatic renal cell carcinoma patients.
Topics: Blood Flow Velocity; Blood Volume; Carcinoma, Renal Cell; Contrast Media; Four-Dimensional Computed | 2018 |
Usefulness of rapid kV-switching dual energy CT in renal tumor characterization.
Topics: Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Angiomyolipoma; Biopsy; Carcinoma, Renal Cell; C | 2019 |
Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.
Topics: Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Renal Cell; Contrast Medi | 2019 |
Use of Iodine Concentration in the Lipid-Poor Portion of the Renal Mass for Differentiation of Angiomyolipoma from Renal Cell Carcinoma.
Topics: Adult; Aged; Angiomyolipoma; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Female; | 2019 |
Differentiation of papillary renal cell carcinoma subtypes on CT and MRI.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differenti | 2013 |
Comparison of segmental enhancement inversion on biphasic MDCT between small renal oncocytomas and chromophobe renal cell carcinomas.
Topics: Adenoma, Oxyphilic; Adult; Aged; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Fem | 2013 |
Renal carcinomas associated with Xp11.2 translocations: are CT findings suggestive of the diagnosis?
Topics: Adolescent; Adult; Carcinoma, Renal Cell; Child; Contrast Media; Female; Humans; Iohexol; Kidney Neo | 2014 |
Transitional cell and clear cell renal carcinoma: differentiation of distinct histological types with multiphase CT.
Topics: Aged; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Contrast Media; Female; Humans; Iohexol; | 2014 |
Angiomyolipoma with minimal fat and non-clear cell renal cell carcinoma: differentiation on MDCT using classification and regression tree analysis-based algorithm.
Topics: Adipose Tissue; Adult; Aged; Algorithms; Angiomyolipoma; Carcinoma, Renal Cell; Contrast Media; Diag | 2014 |
Late emergence of contrast-enhancing fat necrosis mimicking tumor seeding after renal cryoablation.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Renal Cell; Contrast Media; Cryosurgery; Diagnosis, Differen | 2014 |
Clear cell renal cell carcinoma: multiphasic MDCT enhancement can predict the loss of chromosome 8p.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Chromosomes, Human, Pair 8; Contrast Media; C | 2014 |
Revised Choi imaging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinib.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Contrast Media; Fema | 2014 |
CT texture analysis of renal masses: pilot study using random forest classification for prediction of pathology.
Topics: Adenoma, Oxyphilic; Aged; Carcinoma, Renal Cell; Contrast Media; Female; Humans; Iohexol; Kidney Dis | 2014 |
Papillary renal cell carcinoma and clear cell renal cell carcinoma: Differentiation of distinct histological types with contrast - enhanced ultrasonography.
Topics: Adult; Aged; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Female; Humans; Image E | 2015 |
Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication.
Topics: Aged; Aged, 80 and over; Carcinoma, Renal Cell; Cohort Studies; Contrast Media; Family Conflict; Fem | 2015 |
Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas.
Topics: Adult; Aged; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Carcinoma, Renal Cell; Chr | 2015 |
Usefulness of MDCT to Differentiate Between Renal Cell Carcinoma and Oncocytoma: Development of a Predictive Model.
Topics: Adenoma, Oxyphilic; Aged; Algorithms; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential | 2016 |
Small (<4 cm) clear cell renal cell carcinoma: correlation between CT findings and histologic grade.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Contrast Media; Female; Humans; Iohexol; Iopa | 2016 |
A practical imaging classification for the non-invasive differentiation of renal cell carcinoma into its main subtypes.
Topics: Aged; Carcinoma, Papillary; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Female; | 2017 |
Quantitative iodine content threshold for discrimination of renal cell carcinomas using rapid kV-switching dual-energy CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Carcinoma, Renal Cell; Contrast Media; Cysts; | 2017 |
Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector com
Topics: Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Algorithms; Angiomyolipoma; Biopsy; Carcinoma, P | 2017 |
Functional computed tomography imaging of tumor-induced angiogenesis: preliminary results of new tracer kinetic modeling using a computer discretization approach.
Topics: Adult; Aged; Angiography, Digital Subtraction; Carcinoma, Renal Cell; Computer Simulation; Contrast | 2008 |
Whole-body MRI in follow-up of patients with renal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Renal Cell; Contrast Media; Female; Gadolinium DTPA; Humans; Image Interpret | 2010 |
Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy.
Topics: Adult; Aged; Angiogenesis Inhibitors; Benzenesulfonates; Carcinoma, Renal Cell; Contrast Media; Dise | 2010 |
Small renal oncocytomas: differentiation with multiphase CT.
Topics: Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Diagnosis, Differential; | 2011 |
Clear cell renal cell carcinoma: multiphasic multidetector CT imaging features help predict genetic karyotypes.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Chromosomes, Human, Pair 5; Chromosomes, Huma | 2011 |
Subtype differentiation of small renal cell carcinomas on three-phase MDCT: usefulness of the measurement of degree and heterogeneity of enhancement.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Fema | 2012 |
Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Fema | 2012 |
Dynamic MDCT of the pancreas: is time-density curve morphology useful for the differential diagnosis of solid lesions? A preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Huma | 2012 |
Embolisation of bone metastases from renal cancer.
Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Bone Neoplasms; Carcinoma, Renal C | 2013 |
Renal cell carcinoma: value of multiphase MDCT with multiplanar reformations in the detection of pseudocapsule.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Chi-Square Distribution; Contrast Media; Fema | 2012 |
Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Contrast Med | 2013 |
Renal cell carcinoma metastases to the pancreas: value of arterial phase imaging at MDCT.
Topics: Aged; Aged, 80 and over; Biopsy; Carcinoma, Renal Cell; Contrast Media; Female; Humans; Iohexol; Kid | 2013 |
Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers.
Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Blood Volume; Carcinoma, Renal Cell; Contrast Media; F | 2013 |
Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Topics: Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Papillary; Carcinoma, Renal C | 2013 |
Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT.
Topics: Adipose Tissue; Adult; Aged; Angiomyolipoma; Calcinosis; Carcinoma, Renal Cell; Contrast Media; Diag | 2004 |
Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Carcinoma, Renal C | 2004 |
Angiomyolipomas that do not contain fat attenuation at unenhanced CT.
Topics: Adipose Tissue; Angiomyolipoma; Calcinosis; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differ | 2005 |
Small (< or = 3 cm) renal masses: correlation of spiral CT features and pathologic findings.
Topics: Carcinoma, Renal Cell; Diatrizoate; Humans; Image Processing, Computer-Assisted; Iohexol; Kidney; Ki | 1994 |
Dual-phase helical CT of the kidney: value of the corticomedullary and nephrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma.
Topics: Adult; Carcinoma, Renal Cell; Contrast Media; Female; Humans; Image Processing, Computer-Assisted; I | 1997 |
[The staging of renal-cell carcinomas in MRT and CT--a prospective histologically controlled study].
Topics: Adult; Aged; Carcinoma, Renal Cell; Contrast Media; Female; Gadolinium DTPA; Humans; Iohexol; Kidney | 1998 |
Renal masses--evaluation by amplitude coded colour Doppler sonography and multiphasic contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Fema | 1999 |
Atypical contrast reactions associated with systemic interleukin-2 therapy.
Topics: Carcinoma, Renal Cell; Contrast Media; Humans; Immunotherapy, Adoptive; Injections, Intravenous; Int | 1991 |